Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q1- Text added to 2016 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
accelerate, adhesive, AdVersa, Advisory, Aigner, aim, alliance, American, analytical, asthma, attractive, Austria, barrier, Biopharma, blood, brain, branded, call, Cary, cellular, codified, cognitive, collaborating, complex, contingent, cord, Cosmetic, create, crucially, decision, deemed, degenerative, dementia, developmental, disease, efficacy, EITF, embedded, enrolled, explained, Expressedin, Extractive, failure, Federal, field, forward, functionally, Gas, goal, head, Hedging, ii, iii, impairment, insignificant, Institute, leukotriene, lifecycle, living, Ludwig, Medicine, member, mild, minimize, molecular, montelukast, mucosal, neurodegenerative, neuroscientist, Observer, opportunity, phase, plant, population, predefined, primary, profitable, promote, put, regeneration, Regenerative, register, reproducing, rescinding, Rescission, safety, Salzburg, Scientific, sequence, shorter, shortly, signaling, simplification, spinal, structurally, substance, SWK, trial, underlying, University, viable, visualize, XL®to
Valuein 2016 Q1 filing- Value in 2016 Q2 filing
Original filings
Filing view